Dyadic

Dyadic International Eyes Growth in Health and Proteins By Investing.com

Stocks

In the first quarter of 2024, Dyadic International (ticker: NASDAQ:) held a conference call where CEO Mark Emalfarb elaborated on the company’s strategic advancements and financial performance. Dyadic International has made notable progress in the human health sector, particularly with its COVID-19 vaccine candidate showing promising Phase 1 trial results.…